Quick Answer
INTELLIGENT BIO SOLUTIONS INC. reported Operating Income Loss of -$10.64 million for the year ending 2025.
- INTELLIGENT BIO SOLUTIONS INC. showed a decrease of -3.5% in Operating Income Loss from 2024 to 2025.
- This data is from INTELLIGENT BIO SOLUTIONS INC.'s annual report (Form 10-K), filed with the SEC on August 15, 2025.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q4 2019: -$1.70 million | Q1 2020: -$28.8 thousand | Q3 2020: -$663.0 thousand | Q4 2020: -$917.3 thousand | Q1 2021: -$3.14 million | Q3 2021: -$1.44 million | Q4 2021: -$3.47 million | Q1 2022: -$1.34 million | Q3 2022: -$1.22 million | Q4 2022: -$2.13 million | Q1 2023: -$6.54 million | Q3 2023: -$2.53 million | Q4 2023: -$1.99 million | Q1 2024: -$2.95 million | Q3 2024: -$2.73 million | Q4 2024: -$2.26 million | Q1 2025: -$2.55 million | Q3 2025: -$3.00 million | Q4 2025: -$2.64 million.
- Over the full 6 years of available data (2020 to 2025), INTELLIGENT BIO SOLUTIONS INC.'s Operating Income Loss has declined by 272.6%.
- Historical annual values: Fiscal year 2025: -$10.64 million | Fiscal year 2024: -$10.28 million | Fiscal year 2023: -$12.60 million | Fiscal year 2022: -$8.34 million | Fiscal year 2021: -$5.57 million | Fiscal year 2020: -$2.86 million.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: